Skip to main content
. Author manuscript; available in PMC: 2018 Sep 20.
Published in final edited form as: Pain. 2018 Sep;159(9):1856–1866. doi: 10.1097/j.pain.0000000000001282

Fig. 3. [18F]-FDPN tracer binding in control rat brain to validate the tracer.

Fig. 3

Values displayed are normalized with the cerebellum as reference region, mean +/- standard deviation. A one-way ANOVA contrasting all brain regions was found to be significant F22,368 = 284.251, p < 0.001 with posthoc analysis contrasting each brain region to the cerebellum found each region to be significantly different than the cerebellum which is devoid of opioid receptors (p < 0.001).